In breast cancer, synergism between CD8+ T cells and γδ T cells has been described in the eradication of tumor cells including CSCs: γδ T cells induced upregulation of MHC class I and CD54/ICAM-1 on CSCs, enhancing their susceptibility to CD8+ T cells [225]. The gene discussed is ICAM1; the disease is neoplasm.